4.50 USD
↘ 0.08 (1.75%)AT CLOSE (03:59 PM EDT)
Kyntra Bio, Inc. Common Stock
KYNBNASDAQ • USD
4.43
↘ 0.08 (1.67%)
POST MARKET (AS OF 04:00 PM EDT)
Post Market
AS OF 04:00 PM EDT
4.43
↘ 0.08 (1.67%)
Market: CLOSED
Kyntra Bio, Inc. Common Stock (KYNB) trades at $4.68 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, KYNB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.60
High?$4.65
Low?$4.36
Prev. Close?$4.58
Volume?30.1K
Avg. Volume?25.6K
VWAP?$4.48
Rel. Volume?1.17x
Bid / Ask
Bid?$3.21 × 100
Ask?$6.19 × 100
Spread?$2.98
Midpoint?$4.70
Valuation & Ratios
Market Cap?18.2M
Shares Out?4.0M
Float?3.9M
Float %?95.7%
P/E Ratio?0.10
P/B Ratio?-0.60
EPS?$45.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Themes
Employees
34
Market Cap
18.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?2.45%Low
Short Interest?95.0K
Days to Cover?3.6
Free Float3.9M
Avg Daily Volume26.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.69Strong
Quick Ratio?2.59Strong
Cash Ratio?1.41Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score93/100
P/E?0.1CHEAP▾
Peers100
S&P97
P/B?-0.60CHEAP▾
S&P97
P/S?3.95FAIR▾
Peers100
S&P38
P/FCF?N/A▾
EV/EBITDA?0.7CHEAP▾
Peers100
S&P97
EV/Sales?-7.02CHEAP▾
S&P97
Returns & Efficiency
ROE?-607.7%WEAK▾
S&P3
ROA?181.2%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-38062000
Enterprise Value?$-32422942
Fundamentals ratios updated end of day